When was Allied Patients founded?

Allied Patients was founded in 2018.

Where is Allied Patients located?

Allied Patients is headquartered in Kailua, United States.

Who is the current CEO of Allied Patients?

Eduardo Matto of Allied Patients. They have also founded 1 company.

Where does Allied Patients rank among its competitors?

Allied Patients ranks 1228th amongst 1239 active competitors, of which 43 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Laboratorio Reig Jofre, which secured $14.7M in May, 2025.

Who are the top competitors of Allied Patients?

Allied Patients' top competitors include Bayer, Teva Pharmaceuticals and Wockhardt. Among them, Laboratorio Reig Jofre secured the most recent funding round in May, 2025.

Allied Patients - 2026 Company Profile, Team & Competitors

Company Details

Allied Patients manufactures generic finished dosage forms. They offer their products of various therapeutic categories. They also provide patient education services.

Website: alliedpatients.com
Email ID: *****@alliedpatients.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Kailua, United States

Stage

Deadpooled

Ranked

1228^th among 1239 active competitors

Similar Companies

Teva Pharmaceuticals & 1463 more

View Allied Patients' full profile

Allied Patients has not raised any funding rounds yet.

The founders of Allied Patients is Eduardo Matto. Eduardo Matto is the CEO of Allied Patients.

Here are the details of Allied Patients' key team members:

Eduardo Matto: Founder & CEO of Allied Patients.

View details of Allied Patients's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Allied Patients include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of Allied Patients, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
3rd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
4th	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
5th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
6th	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Morgan Stanley, IMM Private Equity & 11 others	69/100
7th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
8th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
9th	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
10th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 2 others	68/100
1228th	Allied Patients 2018, Kailua (United States), Deadpooled	Manufacturer of generic tablets, capsules, and injectables	-	-	18/100